Nobel Laureate Jennifer Doudna, Ph.D. was honored with the Hope Funds for Cancer Research Award of Excellence on May 4 during a black tie event held at a private club in New York City. The presentation took place during a formal dinner recognizing Hope Funds Fellows and Scientists, and was attended by supporters, alumni and grantees of the organization, which is dedicated to advancing innovative research for the most difficult-to-treat cancers. Speakers at the event included Hope Funds Trustee Richard Young, Ph.D. of the Whitehead Institute for Biomedical Research at MIT; Parks Family Hope Funds Fellow Alexander Peterson, Ph.D., a postdoctoral fellow at Scripps Research Institute; and Dr. Doudna, who was presented the Hope Funds Award of Excellence for Basic Science by Don W. Cleveland, Ph.D., Hope Funds Trustee and Chair, Department of Cellular and Molecular Medicine at the University of California, San Diego. Dr. Doudna, along with Emmanuelle Charpentier, was awarded the 2020 Nobel Prize in Chemistry for their development of CRISPR-Cas9 genetic scissors, a precise method for genome editing. The revolutionary technology allows researchers to edit the DNA of plants, animals, and microorganisms with extremely high precision, significantly impacting medicine and agriculture. Dr. Doudna was to have been presented with the Award of Excellence in 2020, but that event was canceled due to the onset of the COVID pandemic. The Award honors those who have made outstanding contributions to basic, clinical, and medical research in cancer or have conducted prominent advocacy and philanthropy on behalf of cancer research. Chairs for the black-tie dinner were Mr. Gary Jobson, Dr. Frank Slack, and Dr. Young. Dr. Joan Steitz and Mr. & Mrs. William D. Rueckert were Honorary Chairs. Eighty guests attended the event, which provides support for programmatic activities and to raise funds for postdoctoral fellowships in cancer research. to view photos please click on this link PHOTO
Posts
No comments:
Post a Comment